HEADER CELL ADHESION 15-MAR-10 3M6F TITLE CD11A I-DOMAIN COMPLEXED WITH 6-((5S,9R)-9-(4-CYANOPHENYL)-3-(3,5- TITLE 2 DICHLOROPHENYL)-1-METHYL-2,4-DIOXO-1,3,7- TRIAZASPIRO[4.4]NON-7-YL) TITLE 3 NICOTINIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-L; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 154-332; COMPND 5 SYNONYM: LEUKOCYTE ADHESION GLYCOPROTEIN LFA-1 ALPHA CHAIN, LFA-1A, COMPND 6 LEUKOCYTE FUNCTION-ASSOCIATED MOLECULE 1 ALPHA CHAIN, CD11 ANTIGEN- COMPND 7 LIKE FAMILY MEMBER A; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITGAL, CD11A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11C KEYWDS LFA1, INHIBITOR, ALTERNATIVE SPLICING, CALCIUM, CELL ADHESION, KEYWDS 2 DISULFIDE BOND, GLYCOPROTEIN, INTEGRIN, MAGNESIUM, MEMBRANE, KEYWDS 3 POLYMORPHISM, RECEPTOR, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 5 06-SEP-23 3M6F 1 REMARK SEQADV REVDAT 4 11-APR-18 3M6F 1 REMARK REVDAT 3 04-APR-18 3M6F 1 REMARK REVDAT 2 19-MAY-10 3M6F 1 JRNL REVDAT 1 12-MAY-10 3M6F 0 JRNL AUTH S.H.WATTERSON,Z.XIAO,D.S.DODD,D.R.TORTOLANI,W.VACCARO, JRNL AUTH 2 D.POTIN,M.LAUNAY,D.K.STETSKO,S.SKALA,P.M.DAVIS,D.LEE,X.YANG, JRNL AUTH 3 K.W.MCINTYRE,P.BALIMANE,K.PATEL,Z.YANG,P.MARATHE,P.KADIYALA, JRNL AUTH 4 A.J.TEBBEN,S.SHERIFF,C.Y.CHANG,T.ZIEMBA,H.ZHANG,B.C.CHEN, JRNL AUTH 5 A.J.DELMONTE,N.ARANIBAR,M.MCKINNON,J.C.BARRISH,S.J.SUCHARD, JRNL AUTH 6 T.G.MURALI DHAR JRNL TITL SMALL MOLECULE ANTAGONIST OF LEUKOCYTE FUNCTION ASSOCIATED JRNL TITL 2 ANTIGEN-1 (LFA-1): STRUCTURE-ACTIVITY RELATIONSHIPS LEADING JRNL TITL 3 TO THE IDENTIFICATION OF JRNL TITL 4 6-((5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL) JRNL TITL 5 -1-METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO[4.4]NONAN-7-YL) JRNL TITL 6 NICOTINIC ACID (BMS-688521). JRNL REF J.MED.CHEM. V. 53 3814 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20405922 JRNL DOI 10.1021/JM100348U REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.POTIN,M.LAUNAY,F.MONATLIK,P.MALABRE,M.FABREGUETTES, REMARK 1 AUTH 2 A.FOUQUET,M.MAILLET,E.NICOLAI,L.DORGERET,F.CHEVALLIER, REMARK 1 AUTH 3 D.BESSE,M.DUFORT,F.CAUSSADE,S.Z.AHMAD,D.K.STETSKO,S.SKALA, REMARK 1 AUTH 4 P.M.DAVIS,P.BALIMANE,K.PATEL,Z.YANG,P.MARATHE,J.POSTELNECK, REMARK 1 AUTH 5 R.M.TOWNSEND,S.SHERIFF,H.EINSPAHR,K.KISH,M.F.MALLEY, REMARK 1 AUTH 6 J.Z.GOUGOUTAS,P.KADIYALA,D.L.CHENEY,R.W.TEJWANI,D.K.MURPHY, REMARK 1 AUTH 7 K.W.MCINTYRE,X.YANG,S.CHAO,L.LEITH,Z.XIAO,A.MATHUR, REMARK 1 AUTH 8 B.-C.CHEN,D.-R.WU,S.C.TRAEGER,M.MCKINNON,J.C.BARRISH, REMARK 1 AUTH 9 J.A.ROBL,E.J.IWANOWICZ,S.J.SUCHARD,T.G.M.DHAR REMARK 1 TITL DISCOVERY AND DEVELOPMENT OF REMARK 1 TITL 2 5-[(5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL) REMARK 1 TITL 3 -1-METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO REMARK 1 TITL 4 [4.4]NON-7-YL]METHYL]-3-THIOPHENECARBOXYLICACID (BMS-587101) REMARK 1 TITL 5 -- SMALL MOLECULE ANTAGONIST OF LFA-1 REMARK 1 REF J.MED.CHEM. V. 49 6946 2006 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 17125246 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1179626.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 13520 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 685 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1930 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1920 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 685 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0090 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 13520 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1339 REMARK 3 BIN R VALUE (WORKING SET) : 0.2140 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 69 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.033 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1451 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 101 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.96000 REMARK 3 B22 (A**2) : 2.02000 REMARK 3 B33 (A**2) : -1.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.10 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.680 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.200 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.710 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.980 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.710 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 48.92 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : BJZ.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : COMBINED.TOP REMARK 3 TOPOLOGY FILE 5 : BJZ.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3M6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1000058166. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100.000000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MICROMAX CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13552 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1LFA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.30000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.55000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.55000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.30000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 125 REMARK 465 SER A 126 REMARK 465 HIS A 127 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 128 CB CG SD CE REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 145 CG OD1 OD2 REMARK 480 LYS A 268 CD CE NZ REMARK 480 ASP A 290 CG OD1 OD2 REMARK 480 GLU A 301 CD OE1 OE2 REMARK 480 GLN A 303 CD OE1 NE2 REMARK 480 TYR A 307 OXT REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 164 -169.19 -121.79 REMARK 500 SER A 174 -105.54 -147.80 REMARK 500 LEU A 204 -131.13 -124.39 REMARK 500 ASP A 244 -159.63 -103.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BJZ A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 A 401 DBREF 3M6F A 129 307 UNP P20701 ITAL_HUMAN 154 332 SEQADV 3M6F GLY A 125 UNP P20701 EXPRESSION TAG SEQADV 3M6F SER A 126 UNP P20701 EXPRESSION TAG SEQADV 3M6F HIS A 127 UNP P20701 EXPRESSION TAG SEQADV 3M6F MET A 128 UNP P20701 EXPRESSION TAG SEQRES 1 A 183 GLY SER HIS MET ASN VAL ASP LEU VAL PHE LEU PHE ASP SEQRES 2 A 183 GLY SER MET SER LEU GLN PRO ASP GLU PHE GLN LYS ILE SEQRES 3 A 183 LEU ASP PHE MET LYS ASP VAL MET LYS LYS LEU SER ASN SEQRES 4 A 183 THR SER TYR GLN PHE ALA ALA VAL GLN PHE SER THR SER SEQRES 5 A 183 TYR LYS THR GLU PHE ASP PHE SER ASP TYR VAL LYS ARG SEQRES 6 A 183 LYS ASP PRO ASP ALA LEU LEU LYS HIS VAL LYS HIS MET SEQRES 7 A 183 LEU LEU LEU THR ASN THR PHE GLY ALA ILE ASN TYR VAL SEQRES 8 A 183 ALA THR GLU VAL PHE ARG GLU GLU LEU GLY ALA ARG PRO SEQRES 9 A 183 ASP ALA THR LYS VAL LEU ILE ILE ILE THR ASP GLY GLU SEQRES 10 A 183 ALA THR ASP SER GLY ASN ILE ASP ALA ALA LYS ASP ILE SEQRES 11 A 183 ILE ARG TYR ILE ILE GLY ILE GLY LYS HIS PHE GLN THR SEQRES 12 A 183 LYS GLU SER GLN GLU THR LEU HIS LYS PHE ALA SER LYS SEQRES 13 A 183 PRO ALA SER GLU PHE VAL LYS ILE LEU ASP THR PHE GLU SEQRES 14 A 183 LYS LEU LYS ASP LEU PHE THR GLU LEU GLN LYS LYS ILE SEQRES 15 A 183 TYR HET BJZ A 1 37 HET NO3 A 401 4 HETNAM BJZ 6-[(5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1- HETNAM 2 BJZ METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO[4.4]NON-7- HETNAM 3 BJZ YL]PYRIDINE-3-CARBOXYLIC ACID HETNAM NO3 NITRATE ION FORMUL 2 BJZ C26 H19 CL2 N5 O4 FORMUL 3 NO3 N O3 1- FORMUL 4 HOH *101(H2 O) HELIX 1 1 GLN A 143 LEU A 161 1 19 HELIX 2 2 ASP A 182 LYS A 190 1 9 HELIX 3 3 ASP A 191 LEU A 196 1 6 HELIX 4 4 ASN A 207 VAL A 219 1 13 HELIX 5 5 ARG A 221 GLY A 225 5 5 HELIX 6 6 ILE A 248 LYS A 252 5 5 HELIX 7 7 LYS A 263 GLN A 266 5 4 HELIX 8 8 THR A 267 GLU A 272 1 6 HELIX 9 9 THR A 273 ALA A 278 5 6 HELIX 10 10 PRO A 281 PHE A 285 1 5 HELIX 11 11 GLU A 293 LYS A 305 1 13 SHEET 1 A 6 TYR A 177 PHE A 181 0 SHEET 2 A 6 TYR A 166 PHE A 173 -1 N GLN A 172 O LYS A 178 SHEET 3 A 6 VAL A 130 ASP A 137 1 N LEU A 132 O GLN A 167 SHEET 4 A 6 THR A 231 THR A 238 1 O ILE A 235 N VAL A 133 SHEET 5 A 6 ILE A 255 ILE A 261 1 O ILE A 259 N ILE A 236 SHEET 6 A 6 VAL A 286 LEU A 289 1 O LYS A 287 N GLY A 260 CISPEP 1 LYS A 280 PRO A 281 0 -2.39 SITE 1 AC1 10 TYR A 166 THR A 231 ILE A 235 ILE A 255 SITE 2 AC1 10 TYR A 257 ILE A 259 LYS A 287 LEU A 302 SITE 3 AC1 10 HOH A 408 HOH A 447 SITE 1 AC2 5 LYS A 276 LYS A 280 HOH A 444 HOH A 460 SITE 2 AC2 5 HOH A 491 CRYST1 40.600 63.600 63.100 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024631 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015723 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015848 0.00000